Search
SOLACI Congress
HomeFile

File

View Category
Acute coronary syndromes

Invasive Strategy in Frail Patients Is Safe

Courtesy of Dr. Carlos Fava. The current population of frail and elderly patients is increasing, and while non-ST-segment acute...
solaci -
Learn More
Chronic Ischemic cardiopathy

Should Sex Be Taken into Account with Left Main Coronary Artery Revascularization?

The EXCEL trial did not find the sex of patients with left main coronary artery disease to...
solaci -
Learn More
Structural heart disease

Differences in Debris Captured According to Valve Type

During valve replacement, cerebral protection systems may capture debris in up to 99% of all patients. In...
solaci -
Learn More
Mitral valve

MitraClip in Severe MR: 5 Year Mortality Rate Similar to Surgery

Courtesy of Dr. Carlos Fava. Mitral regurgitation accounts for around 25% of valvular diseases and is a strong...
solaci -
Learn More
Other

Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators

Endovascular therapy is now considered as the standard of care for acute ischemic stroke caused by large...
solaci -
Learn More
Coronary disease

New Ultra-Thin-Strut DES: Do They Outperform Second-Generation DES?

The new drug-eluting stents (DES) equipped with ultra-thin struts are showing a lower risk of target lesion...
solaci -
Learn More
Mitral valve

Treating Tricuspid and Mitral Valves with MitraClip Improves Quality of Life

Courtesy of Dr. Carlos Fava. It has been shown that significant tricuspid regurgitation (TR) is an independent predictor...
solaci -
Learn More
Mitral valve

Tricuspid Regurgitation: MitraClip Improves Survival

Courtesy of Dr. Carlos Fava. Tricuspid regurgitation (TR), both isolated or associated with other left valve diseases, has...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

Dr. Juan Manuel Pérez - 0
This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Left or Right Transradial Approach? Comparing Radiation Exposure in Coronary Procedures

Dr. Juan Manuel Pérez - 0
Radiation exposure during percutaneous procedures is a problem both for patients and operators. The transradial is currently the preferred approach, vs. femoral; however, whether...

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy